Search for: "Stem Cell Growth, Inc."
Results 21 - 40
of 41
Sort by Relevance
|
Sort by Date
11 Apr 2012, 9:57 pm
” Theatre Enters., Inc. v. [read post]
15 Aug 2011, 2:00 am
Patentable Unpatentable A method for screening potential cancer therapeutics which comprises: growing a transformed eukaryotic host cell containing an altered BRCA1 gene causing cancer in the presence of a compound suspected of being a cancer therapeutic, growing said transformed eukaryotic host cell in the absence of said compound, determining the rate of growth of said host cell in the presence of said compound and the rate of… [read post]
15 Aug 2011, 2:00 am
Patentable Unpatentable A method for screening potential cancer therapeutics which comprises: growing a transformed eukaryotic host cell containing an altered BRCA1 gene causing cancer in the presence of a compound suspected of being a cancer therapeutic, growing said transformed eukaryotic host cell in the absence of said compound, determining the rate of growth of said host cell in the presence of said compound and the rate of… [read post]
18 Apr 2011, 12:15 pm
Researchers across the United States use this technology to study cancer, stem cells, diabetes, cartilage and nerve growth, and infectious disease. [read post]
25 Jan 2011, 12:30 pm
Burns was named by the President to help lead the White House national campaign on STEM (science, technology, engineering and math) education in November 2009, and is on the board of Change the Equation, a coalition of over 100 CEOs focused on STEM education that the President announced in September 2010. [read post]
18 Aug 2010, 7:23 am
Obamacare has landed in Denver, where doctors at a pain-management clinic have been told they must stop treating patients with a successful process that extracts their own adult stem cells, cultivates them and then reinjects them to stimulate growth in damaged limbs. [read post]
12 Apr 2010, 2:07 pm
Part 1271 Human Cells, Tissues, and Cellular and Tissue-Based Products regulations (“HCT/P regulations”) of RSI’s autologous, mesenchymal stem cell (“MSC”) Regenexx™ Procedure for treatment of musculoskeletal and spinal injuries. [read post]
16 Feb 2010, 9:17 am
Jacobsen Products Company Inc., where Qualitex manufactured pads for dry cleaning presses. [read post]
11 Jun 2009, 2:12 pm
Simpson] reported that Philip Schwartz, head of the Resource, said his organization's efforts to promote research with human neural stem cells has been effectively blocked by patents held by Stem Cells Inc ["SCI"].The patent issue had been widely circulated: Simpson's piece was the result of a notice by Schwartz to about 2,700 persons, mostly academics, about the patent issue. [read post]
10 Mar 2009, 7:38 am
Mar 9: As part of the well publicized signing of Stem Cell Executive Order, President Obama also signed a separate Presidential Memorandum On Scientific Integrity. [read post]
10 Feb 2009, 9:39 am
Section 2 presents the outcomes of research on global trends in intellectual property claims over microorganisms and highlights the way in which the TRIPS agreement inclusion of microorganisms as patentable subject matter has been extended to the classification of stem cell material as a microorganism. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo… [read post]
16 May 2008, 8:03 am
, (IPRoo), StemCells files second patent lawsuit against Neuralstem in relation to human neural stem cells: (IPBiz), (IP Law360), (Patent Docs), (California Biotech Law Blog), Patent Reform Act removed from Senate calendar: (Peter Zura's 271 Patent Blog), (IAM), (Managing Intellectual Property), (IP Law360), Global Global - General New WIPO Director General: Francis Gurry of Australia: (WIPO), (Managing Intellectual Property), (Innovationpartners), (IAM),… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
21 Jun 2007, 1:45 am
Documents listed are accessible through subscription to the GalleryWatch.com service
06/20/2007
Expanding Approved Stem Cell Lines In Ethically Responsible Ways Executive order issued by the president on June 20, 2007 06/20/2007
GAO Correspondence to Chairs and Ranking Members, Senate Finance Committee and Health, Education, Labor and Pensions Committee (PDF 316 KB) PBGC's Legal Support: Improvements Needed to Eliminate Confusion and… [read post]
14 May 2007, 12:52 am
And the firm showed above-average growth rates in revenue per lawyer and value per lawyer. [read post]
